| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |